These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23497543)

  • 1. What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy.
    Toramatsu C; Katoh N; Shimizu S; Nihongi H; Matsuura T; Takao S; Miyamoto N; Suzuki R; Sutherland K; Kinoshita R; Onimaru R; Ishikawa M; Umegaki K; Shirato H
    Radiat Oncol; 2013 Mar; 8():48. PubMed ID: 23497543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Tsai SY; Cheng SH; Jian JJ; Huang AT
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):229-34. PubMed ID: 12694843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTCP modeling analysis of acute hematologic toxicity in whole pelvic radiation therapy for gynecologic malignancies - A dosimetric comparison of IMRT and spot-scanning proton therapy (SSPT).
    Yoshimura T; Kinoshita R; Onodera S; Toramatsu C; Suzuki R; Ito YM; Takao S; Matsuura T; Matsuzaki Y; Umegaki K; Shirato H; Shimizu S
    Phys Med; 2016 Sep; 32(9):1095-102. PubMed ID: 27567089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the risk for radiation-induced liver disease following photon- or proton-beam radiosurgery of liver metastases.
    Mondlane G; Ureba A; Gubanski M; Lind PA; Siegbahn A
    Radiat Oncol; 2018 Oct; 13(1):206. PubMed ID: 30348194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential dosimetric benefit of proton beam therapy over intensity modulated radiotherapy for a variety of targets in patients with intracranial germ cell tumors.
    Park J; Park Y; Lee SU; Kim T; Choi YK; Kim JY
    Radiat Oncol; 2015 Jun; 10():135. PubMed ID: 26112360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of dosimetric variations of liver radiotherapy using deformable registration of planning CT and cone-beam CT.
    Huang P; Yu G; Chen J; Ma C; Qin S; Yin Y; Liang Y; Li H; Li D
    J Appl Clin Med Phys; 2017 Jan; 18(1):66-75. PubMed ID: 28291931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative dosimetric study of spot-scanning proton therapy versus volumetric-modulated radiation therapy for extrahepatic bile duct cancer.
    Ogata T; Aibe N; Kimoto T; Takenaka T; Suzuki G; Yamada K; Yamazaki H
    Med Dosim; 2024 Spring; 49(1):46-49. PubMed ID: 37925300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications of IMRT, PRT and CIRT for HCC from comparisons of dosimetry and normal tissue complication possibility.
    Sun J; Wang Z; Sheng Y; Ming X; Jiang GL; Wang W
    Strahlenther Onkol; 2022 Apr; 198(4):361-369. PubMed ID: 34618172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of liver protection among 3-D conformal radiotherapy, intensity-modulated radiotherapy and RapidArc for hepatocellular carcinoma.
    Chen D; Wang R; Meng X; Liu T; Yan H; Feng R; Liu S; Jiang S; Xu X; Zhu K; Dou X
    Radiat Oncol; 2014 Feb; 9():48. PubMed ID: 24502643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy.
    Kuo YC; Chiu YM; Shih WP; Yu HW; Chen CW; Wong PF; Lin WC; Hwang JJ
    Radiat Oncol; 2011 Jun; 6():76. PubMed ID: 21693003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment planning study to determine potential benefit of intensity-modulated radiotherapy versus conformal radiotherapy for unresectable hepatic malignancies.
    Eccles CL; Bissonnette JP; Craig T; Taremi M; Wu X; Dawson LA
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):582-8. PubMed ID: 18793961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric comparison between carbon, proton and photon radiation for renal retroperitoneal soft tissue sarcoma recurrence or metastasis after radical nephrectomy.
    Ming X; Wang W; Shahnazi K; Sun J; Zhang Q; Li P; Hong Z; Sheng Y
    Int J Radiat Biol; 2022; 98(2):183-190. PubMed ID: 34802361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation.
    Cozzi L; Comito T; Loi M; Fogliata A; Franzese C; Franceschini D; Clerici E; Reggiori G; Tomatis S; Scorsetti M
    Technol Cancer Res Treat; 2020; 19():1533033820980412. PubMed ID: 33287650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RapidArc vs intensity-modulated radiation therapy for hepatocellular carcinoma: a comparative planning study.
    Park JM; Kim K; Chie EK; Choi CH; Ye SJ; Ha SW
    Br J Radiol; 2012 Jul; 85(1015):e323-9. PubMed ID: 22745211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
    Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
    Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters.
    Jung J; Yoon SM; Kim SY; Cho B; Park JH; Kim SS; Song SY; Lee SW; Ahn SD; Choi EK; Kim JH
    Radiat Oncol; 2013 Oct; 8():249. PubMed ID: 24160910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.
    Hsieh CE; Venkatesulu BP; Lee CH; Hung SP; Wong PF; Aithala SP; Kim BK; Rao A; Tung-Chieh Chang J; Tsang NM; Wang CC; Lee CC; Lin CC; Tseng JH; Chou WC; Wang YC; Krishnan S; Hong JH
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):73-86. PubMed ID: 30797890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-pelvic radiotherapy with spot-scanning proton beams for uterine cervical cancer: a planning study.
    Hashimoto S; Shibamoto Y; Iwata H; Ogino H; Shibata H; Toshito T; Sugie C; Mizoe JE
    J Radiat Res; 2016 Sep; 57(5):524-532. PubMed ID: 27380800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric differences among volumetric modulated arc radiotherapy (RapidArc) plans based on different target volumes in radiotherapy of hepatocellular carcinoma.
    Gong G; Yin Y; Guo Y; Liu T; Chen J; Lu J; Ma C; Sun T; Bai T; Zhang G; Li D; Wang R
    J Radiat Res; 2013 Jan; 54(1):182-9. PubMed ID: 22915784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.